Kadmon Holdings, Inc. (KDMN) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
450 EAST 29TH STREET NEW YORK, NY 10016 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 9/30/2021 MRQ | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | |||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash, cash equivalents, and short-term investments | 134,422 | 181,594 | 94,740 | 67,517 | 36,093 | |||
| Cash and cash equivalents | 74,423 | 139,597 | 94,740 | 67,517 | 36,093 | |||
| Short-term investments | 59,999 | 41,997 | ||||||
| Receivables | 695 | 954 | 1,690 | 1,186 | 1,210 | |||
| Inventory, net of allowances, customer advances and progress billings | 102 | 640 | 925 | 201 | 1,950 | |||
| Inventory | 102 | 640 | 925 | 201 | 1,950 | |||
| Deferred costs | 56 | |||||||
| Other undisclosed current assets | 2,082 | 1,416 | 1,581 | 1,109 | 978 | |||
| Total current assets: | 137,301 | 184,604 | 98,936 | 70,013 | 40,287 | |||
| Noncurrent Assets | ||||||||
| Operating lease, right-of-use asset | 16,112 | 19,651 | ✕ | ✕ | ✕ | |||
| Property, plant and equipment | 1,287 | 2,444 | 3,654 | 4,292 | 5,427 | |||
| Long-term investments and receivables | 2,300 | 2,300 | 2,300 | 3,500 | 11,100 | |||
| Long-term investments | 2,300 | 2,300 | 2,300 | 3,500 | 11,100 | |||
| Intangible assets, net (including goodwill) | 3,580 | 3,580 | 3,580 | (137,120) | (137,120) | |||
| Goodwill | 3,580 | 3,580 | 3,580 | 3,580 | 3,580 | |||
| Intangible assets, net (excluding goodwill) | (140,700) | (140,700) | ||||||
| Restricted cash and investments | 2,117 | 2,116 | 2,116 | 2,116 | 2,116 | |||
| Other noncurrent assets | 13 | 103 | 9 | 5 | ||||
| Other undisclosed noncurrent assets | 34,075 | 140,742 | 140,741 | |||||
| Total noncurrent assets: | 25,409 | 30,194 | 45,725 | 13,539 | 22,269 | |||
| TOTAL ASSETS: | 162,710 | 214,798 | 144,661 | 83,552 | 62,556 | |||
| LIABILITIES AND EQUITY | ||||||||
| Liabilities | ||||||||
| Current Liabilities | ||||||||
| Accounts payable and accrued liabilities | 22,467 | 23,291 | 23,494 | 16,585 | 18,446 | |||
| Accounts payable | 10,933 | 9,043 | 9,986 | 8,008 | 6,296 | |||
| Accrued liabilities | 11,534 | 14,248 | 13,508 | 8,577 | 12,150 | |||
| Debt | 1,699 | 3,966 | 33,707 | |||||
| Derivative instruments and hedges, liabilities | 1,082 | 1,485 | 524 | 1,952 | ||||
| Deferred revenue and credits | ✕ | ✕ | ✕ | ✕ | 4,400 | 4,400 | ||
| Other undisclosed current liabilities | 4,223 | 1,900 | ||||||
| Total current liabilities: | 29,471 | 28,742 | 24,018 | 56,644 | 24,746 | |||
| Noncurrent Liabilities | ||||||||
| Long-term debt and lease obligation | 16,938 | 19,759 | 27,480 | 28,677 | ||||
| Long-term debt, excluding current maturities | 1,359 | 27,480 | 28,677 | |||||
| Liabilities, other than long-term debt | 278 | 562 | 4,752 | 25,150 | 34,325 | |||
| Deferred revenue and credits | ✕ | ✕ | ✕ | ✕ | 23,964 | 28,394 | ||
| Deferred rent credit | 4,290 | ✕ | ✕ | |||||
| Deferred tax liabilities, net | ✕ | ✕ | ✕ | 415 | 939 | 1,376 | ||
| Deferred income tax liabilities | 278 | 461 | ✕ | ✕ | ✕ | |||
| Other liabilities | 101 | 47 | 247 | 1,250 | ||||
| Operating lease, liability | 15,579 | 19,759 | ✕ | ✕ | ✕ | |||
| Derivative instruments and hedges, liabilities | 3,305 | |||||||
| Total noncurrent liabilities: | 17,216 | 20,321 | 32,232 | 25,150 | 63,002 | |||
| Total liabilities: | 46,687 | 49,063 | 56,250 | 81,794 | 87,748 | |||
| Equity | ||||||||
| Equity, attributable to parent | 116,023 | 165,735 | 88,411 | (38,462) | (63,539) | |||
| Preferred stock | 44,555 | 42,433 | 42,231 | |||||
| Common stock | 171 | 160 | 113 | 79 | ||||
| Additional paid in capital | 515,429 | 456,211 | 315,710 | 198,856 | 92,166 | |||
| Accumulated other comprehensive loss | (28) | |||||||
| Accumulated deficit | (444,104) | (333,069) | (269,643) | (237,397) | (155,705) | |||
| Other undisclosed equity | 40,220 | 38,347 | ||||||
| Total equity: | 116,023 | 165,735 | 88,411 | 1,758 | (25,192) | |||
| TOTAL LIABILITIES AND EQUITY: | 162,710 | 214,798 | 144,661 | 83,552 | 62,556 | |||
Income Statement (P&L) ($ in thousands)
| 9/30/2021 TTM | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | ||
|---|---|---|---|---|---|---|---|
| Revenues | 8,288 | 5,095 | 1,396 | 12,264 | 26,055 | ||
| Revenue, net | ✕ | ✕ | ✕ | ✕ | 12,264 | 26,055 | |
| Gain on disposition of assets for financial service operations | 19,784 | 22,000 | ✕ | ✕ | |||
| Cost of revenue (Cost of Goods and Services Sold) | (851) | (912) | (682) | (1,654) | (385) | ||
| Other undisclosed gross profit | (1,150) | (377) | (1,332) | (3,485) | |||
| Gross profit: | 6,287 | 3,806 | 714 | 9,278 | 22,185 | ||
| Operating expenses | (108,568) | (92,886) | (86,610) | (77,834) | (137,589) | ||
| Operating loss: | (102,281) | (89,080) | (85,896) | (68,556) | (115,404) | ||
| Nonoperating income (expense) | (6,814) | 27,758 | 31,120 | (11,339) | (93,009) | ||
| Investment income, nonoperating | 1,594 | 1,106 | 36,907 | 2,228 | 4,418 | ||
| Interest and debt expense | 3,684 | (3,381) | (4,619) | (5,962) | (11,176) | ||
| Loss from continuing operations before equity method investments, income taxes: | (105,411) | (64,703) | (59,395) | (85,857) | (219,589) | ||
| Other undisclosed income (loss) from continuing operations before income taxes | (3,684) | 3,381 | 4,619 | 5,962 | 11,176 | ||
| Loss from continuing operations before income taxes: | (109,095) | (61,322) | (54,776) | (79,895) | (208,413) | ||
| Income tax expense (benefit) | 182 | (46) | 524 | 121 | (342) | ||
| Loss from continuing operations: | (108,913) | (61,368) | (54,252) | (79,774) | (208,755) | ||
| Loss before gain (loss) on sale of properties: | ✕ | (108,913) | (61,368) | (54,252) | (79,774) | (208,755) | |
| Net loss attributable to parent: | (108,913) | (61,368) | (54,252) | (79,774) | (208,755) | ||
| Preferred stock dividends and other adjustments | (2,122) | (2,058) | (2,011) | (1,918) | (21,733) | ||
| Net loss available to common stockholders, basic: | (111,035) | (63,426) | (56,263) | (81,692) | (230,488) | ||
| Dilutive securities, effect on basic earnings per share | 26,549 | 10,958 | |||||
| Net loss available to common stockholders, diluted: | (111,035) | (63,426) | (56,263) | (55,143) | (219,530) | ||
Comprehensive Income ($ in thousands)
| 9/30/2021 TTM | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | ||
|---|---|---|---|---|---|---|---|
| Net loss: | (108,913) | (61,368) | (54,252) | (79,774) | (208,755) | ||
| Other comprehensive loss | (28) | ||||||
| Other undisclosed comprehensive loss | (2,122) | ||||||
| Comprehensive loss, net of tax, attributable to parent: | (111,063) | (61,368) | (54,252) | (79,774) | (208,755) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.